Karyopharm Therapeutics

KPTI

KPTI
Karyopharm Therapeutics  Stock Quote
$14.62 -$0.54 -3.6%
Price as of August 14, 2020, 10:30 a.m. EDT View Interactive KPTI Charts

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

Interactive Chart


News & Analysis: Karyopharm Therapeutics

All

Market Moves

Earnings